Page 2639

(3) a protocol for analyzing the use of restrictive intervention each calendar quarter;

(4) a procedure for taking corrective action based on the analysis; and

(5) a process for summarizing the quarterly analyses and corrective action taken under this subsection; the summary must be submitted to the department with the provider’s application to renew certification under 7 AAC 130.220, or upon request. (g) In this section

(1) “restrictive intervention” means an action or procedure that limits an individual’s movement or access to other individuals, locations, or activities;

(2) “seclusion” means the involuntary confinement of an individual alone in a room or an area from which the individual is physically prevented from having contact with others or leaving.

(3) “chemical restraint”

(A) means the use of medication to restrict freedom of movement in order to manage or control behavior, for disciplinary purposes, or for the convenience of the provider;

(B) does not include medication prescribed for the purpose of managing behavior by an individual listed in 7 AAC 130.227(j)(3) and administered in accordance with the applicable requirements of 7 AAC 130.227. (Eff. 7/1/2013, Register 206; am 7/1/2015, Register 214; am 11/5/2017, Register 224; am 3/31/2021, Register 238; am 10/16/2022, Register 244) Statutory Authority: Authority: AS 47.05.010 AS 47.07.030 AS 47.07.040 Editor’s note: As of Register 227 (October 2018), the regulations attorney made a technical correction under AS 44.62.125(b)(6), to 7 AAC 130.229(a). 7 AAC 130.230. Screening, assessment, plan of care, and level-of-care determination. Repealed. (Eff. 2/1/2010, Register 193; am 11/3/2012, Register 204; repealed 7/1/2013, Register 206)